The breast cancer medication Arimidex beats tamoxifen when it comes to preventing recurrences of hormone-receptor-positive breast cancer in postmenopausal women, a new study suggests. Researchers say Arimidex improved disease-free survival by 15 percent compared with tamoxifen. And the medication continued to work even three years after stopping therapy.
Read moreMy name is Doug Haberstroh, and this is the story of my wife Keri. Keri was diagnosed with breast cancer in 2005 at the age of 25. We had... Read more »
It takes just a single moment to change your life forever.It happens in that instant when the doctor looks you in the eye and hesitates,... Read more »
“You’re committing suicide.”That was the chilling statement delivered to one of my friends when she told her oncologist she was... Read more »
My name is Doug Haberstroh, and this is the story of my wife Keri. Keri was diagnosed with breast cancer in 2005 at the age of 25. After... Read more »
My mom, breast cancer survivor Gloria Heyison, and me The five most horrifying words I have ever heard were, "Your mom has breast... Read more »
A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the... Read more »
(Ivanhoe Newswire) -- A drug more commonly associated with breast cancer treatment is holding out new promise for people suffering through the manic... Read more »
If you’ve just learned that you have breast cancer, you may be encountering some of the most anxious moments of your life. Although research has... Read more »
My technician recently told me, just before sending me gliding through an MRI tube, that MRI scans were once an uncommon breast exam. He performed... Read more »
Many survivors of breast cancer report having decreased sexual desire and drive. There are often several possible causes of diminished sex drive in... Read more »